COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 1204: Articles 12031-12040  | Next

Children and adults with mild COVID-19 symptoms develop memory T cell immunity to SARS-CoV-2
Kaaijk, P., Olivo Pimentel, V., Emmelot, M. E., Poelen, M., Cevirgel, A., Schepp, R. M., den Hartog, G., Reukers, D. F. M., Beckers, L., van Beek, J., van Els, C. A. C. M., Meijer, A., Rots, N. Y., de Wit, J.
10.1101/2021.09.10.21263333 — Posted: 2021-09-15
Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severity
Violan, C., Toran, P., Quirant, B., Lamonja-Vicente, N., Carrasco-Ribelles, L. A., Chacon, C., Manresa-Dominguez, J. M., Ramos-Roure, F., Roso-Llorach, A., Pujol, A., Ouchi, D., Monteagudo, M., Montero, P., Garcia-Sierra, R., Armestar, F., Dacosta-Aguayo, R., Dolade, M., Prat, N., Bonet, J. M., Clotet, B., Blanco, I., Prado, J. G., Martinez-Caceres, E. M., ProHEpiC-19 Investigators
10.1101/2021.09.10.21262527 — Posted: 2021-09-15
Localising Vaccination Services: Qualitative Insights on an Orthodox Jewish Collaboration with Public health during the UK coronavirus Vaccine Programme
Kasstan, B., Mounier-Jack, S., Letley, L., Gaskell, K. M., Roberts, C. h., Stone, N., Lal, S., Eggo, R. M., Marks, M., Chantler, T.
10.1101/2021.09.10.21263372 — Posted: 2021-09-15
Social-economic drivers overwhelm climate in underlying the COVID-19 early growth rate
Liu, Z.
10.1101/2021.09.10.21263383 — Posted: 2021-09-15
High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
FABRE, M., CALVO, P., RUIZ-MARTINEZ, S., PERAN, M., OROS, D., MEDEL, A., STRUNK, M., BENITO, R., SCHOORLEMMER, J., PAULES, C.
10.1101/2021.09.07.21261607 — Posted: 2021-09-15
Antibody response to a fourth mRNA Covid-19 vaccine boost in weak responder kidney transplant recipients
Caillard, S., Thaunat, O., Benotmane, I., masset, c., Blancho, G.
10.1101/2021.09.03.21262691 — Posted: 2021-09-15
Evaluation of commercially available high-throughput SARS-CoV-2 serological assays for serosurveillance and related applications
Stone, M., Grebe, E., Sulaeman, H., Di Germanio, C., Dave, H., Kelly, K., Biggerstaff, B., Crews, B. O., Tran, N., Jerome, K., Denny, T. N., Hogema, B., Destree, M., Jones, J. M., Thornburg, N., Simmons, G., Krajden, M., Kleinman, S., Dumont, L. J., Busch, M. P.
10.1101/2021.09.04.21262414 — Posted: 2021-09-15
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Choudhary, M. C., Chew, K. W., Deo, R., Flynn, J. P., Regan, J., Crain, C. R., Moser, C., Hughes, M., Ritz, J., Ribeiro, R. M., Ke, R., Dragavon, J. A., Javan, A. C., Nirula, A., Klekotka, P., Greninger, A. L., Fletcher, C. V., Daar, E. S., Wohl, D. A., Eron, J. J., Currier, J. S., Parikh, U. M., Sieg, S. F., Perelson, A. S., Coombs, R. W., Smith, D. M., Li, J. Z.
10.1101/2021.09.03.21263105 — Posted: 2021-09-15
Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction
Sartor, I. T. S., Varela, F. H., Meireles, M. R., Kern, L. B., Azevedo, T. R., Giannini, G. L. T., da Silva, M. S., Demoliner, M., Gularte, J. S., de Almeida, P. R., Fleck, J. D., Zavaglia, G. O., Fernandes, I. R., de David, C. N., Santos, A. P., de Almeida, W. A. F., Porto, V. B. G., Scotta, M. C., Spilki, F. R., Vieira, G. F., Stein, R. T., Polese-Bonatto, M.
10.1101/2021.09.10.21262695 — Posted: 2021-09-14
A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia
Sanchez, C. A., Li, H., Phelps, K. L., Zambrana-Torrelio, C., Wang, L.-F., Olival, K. J., Daszak, P.
10.1101/2021.09.09.21263359 — Posted: 2021-09-14 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).